Tech Company Financing Transactions
Edgemont Funding Round
Oxford Finance participated in a $5 million funding round for Edgemont. The round was announced by the company on 5/4/2015.
Transaction Overview
Company Name
Announced On
5/4/2015
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Oxford Finance (Christopher Herr)
Proceeds Purpose
The additional funds will be used primarily for working and growth capital.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
North Mopac Expy. 400
Austin, TX 78731
USA
Austin, TX 78731
USA
Phone
Website
Email Address
Not Recorded
Overview
Edgemont Pharmaceuticals focuses on the field of neuroscience and develops novel drug formulations and therapiesto improve patient care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Saltel
Chief Financial Officer
David Lowrance
Controller
Susanne Patterson
Browse more venture capital transactions:
Prev: 5/4/2015: Real Matters venture capital transaction
Next: 5/4/2015: AltSchool venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs